The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer-Reference-Cited by-同舟云学术

The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer

Published:2015-11-13 Issue:12 Volume:15 Page:1605-1629
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Ross Kirsty,Pailler Emma,Faugeroux Vincent,Taylor Melissa,Oulhen Marianne,Auger Nathalie,Planchard David,Soria Jean-Charles,Lindsay Colin R.,Besse Benjamin,Vielh Philippe,Farace Françoise

Funder

EURONCO

Innovative Medicines Initiative

Institut National Du Cancer

LabEx LERMIT

CANCER ID

Fondation de France

Fondation ARC pour la Recherch sur le Cancer

ESMO

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737159.2015.1111139

Reference137 articles.

1. Papers of special note have been highlighted as:

2. • of interest

3. •• of considerable interest

4. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer;British Journal of Cancer;2024-01-04

2. Biomarkers in Cancer Detection, Diagnosis, and Prognosis;Sensors;2023-12-20

3. Insight into Intratumoral Heterogeneity Through Single CTC Sequencing and CDX Analysis;Circulating Tumor Cells;2023

4. Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma;Journal of Immunology Research;2022-05-29

5. En marche vers une oncologie personnalisée : l’apport des techniques génomiques et de l’intelligence artificielle dans l’usage des biomarqueurs tumoraux circulants;Bulletin du Cancer;2022-02